Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.
- DOI
- 10.3390/curroncol33020084
- Published
- 2026 Jan 31
- Container
- Current oncology (Toronto, Ont.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/curroncol33020084,
title = {Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.},
author = {Cheema PK and Perdrizet KA and Sangha RS and Breadner D and Daaboul N and Farley S and Jao K and Liu G and Logan B and Melosky B and Reiman A and Snow S and Yadav S and Kassam S},
year = {2026},
journal = {Current oncology (Toronto, Ont.)},
doi = {10.3390/curroncol33020084},
url = {https://doi.org/10.3390/curroncol33020084}
}RIS
TY - JOUR TI - Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies. AU - Cheema PK AU - Perdrizet KA AU - Sangha RS AU - Breadner D AU - Daaboul N AU - Farley S AU - Jao K AU - Liu G AU - Logan B AU - Melosky B AU - Reiman A AU - Snow S AU - Yadav S AU - Kassam S PY - 2026 JO - Current oncology (Toronto, Ont.) DO - 10.3390/curroncol33020084 UR - https://doi.org/10.3390/curroncol33020084 ER -
APA
PK, C., KA, P., RS, S., D, B., N, D., S, F., K, J., G, L., B, L., B, M., A, R., S, S., S, Y., & S, K. (2026). Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol33020084
Source records
- pubmed · retrieved 2026-09-26T04:18:25.679Z